ARDX
Ardelyx Inc
Price:  
5.69 
USD
Volume:  
2,628,414.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Ardelyx EV/EBITDA

-141.7%
Upside

As of 2026-06-14, the EV/EBITDA ratio of Ardelyx Inc (ARDX) is -47.73. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Ardelyx's latest enterprise value is 1,577.91 mil USD. Ardelyx's TTM EBITDA according to its financial statements is -33.06 mil USD. Dividing these 2 quantities gives us the above Ardelyx EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 7.6x - 14.3x 11.3x
Forward P/E multiples 10.7x - 16.0x 13.7x
Fair Price (2.13) - (2.61) (2.37)
Upside -137.4% - -145.9% -141.7%
5.69 USD
Stock Price
(2.37) USD
Fair Price

Ardelyx EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-06-12 -47.73
2026-06-11 -48.48
2026-06-10 -47.13
2026-06-09 -47.06
2026-06-08 -46.61
2026-06-05 -46.76
2026-06-04 -45.56
2026-06-03 -45.71
2026-06-02 -46.46
2026-06-01 -48.03
2026-05-29 -50.34
2026-05-28 -51.91
2026-05-27 -51.32
2026-05-26 -51.91
2026-05-22 -50.87
2026-05-21 -52.66
2026-05-20 -52.06
2026-05-19 -50.72
2026-05-18 -50.87
2026-05-15 -51.76
2026-05-14 -53.48
2026-05-13 -52.88
2026-05-12 -54.60
2026-05-11 -54.60
2026-05-08 -55.87
2026-05-07 -57.37
2026-05-06 -58.26
2026-05-05 -58.49
2026-05-04 -59.76
2026-05-01 -56.62
2026-04-30 -52.51
2026-04-29 -50.12
2026-04-28 -49.82
2026-04-27 -49.97
2026-04-24 -49.67
2026-04-23 -49.75
2026-04-22 -50.19
2026-04-21 -49.75
2026-04-20 -52.29
2026-04-17 -53.41
2026-04-16 -52.14
2026-04-15 -52.29
2026-04-14 -52.51
2026-04-13 -52.51
2026-04-10 -51.39
2026-04-09 -51.02
2026-04-08 -50.79
2026-04-07 -49.67
2026-04-06 -49.82
2026-04-02 -49.60